Table 3. Medication tolerability, discontinuations, adherence over the 8-week study period.
Variable | Gabapentin | Naltrexone | Placebo | |
---|---|---|---|---|
Medication tolerability | Mean (SD) | 91.0 (26.3) | 90.8 (25.0) | 100.0 (0.0) |
Median (IQR) | 100.0 (100.0, 100.0) | 100.0 (100.0, 100.0) | 100.0 (100.0, 100.0) | |
Permanent treatment discontinuations | N (%) | 4 (26.7%) | 3 (20.0%) | 0 (0.0%) |
Adherence (VAS Score of 0–100) | Mean (SD) | 74.4 (40.4) | 81.5 (32.9) | 96.6 (4.9) |
Median (IQR) | 99.8 (18.0, 100.0) | 99.1 (75.0, 100.0) | 99.2 (93.3, 100.0) |